![]() |
|
|
Vol. 14, Issue 9, 3592-3604, September 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Chester Beatty Laboratories, London SW3 6JB, United Kingdom
Submitted December 12, 2002;
Revised April 28, 2003;
Accepted April 29, 2003
Monitoring Editor: Jean Schwarzbauer
Endo180, a member of the mannose receptor family, is constitutively recycled between clathrin-coated pits on the cell surface and intracellular endosomes. Its large extracellular domain contains an N-terminal cysteine-rich domain, a single fibronectin type II domain and eight C-type lectin-like domains. The second of these lectin-like domains has been shown to mediate Ca2+-dependent mannose binding. In addition, cross-linking studies have identified Endo180 as a urokinase plasminogen activator receptorassociated protein and this interaction can be blocked by collagen V. Here we demonstrate directly using in vitro assays, cell-based studies and tissue immunohistochemistry that Endo180 binds both to native and denatured collagens and provide evidence that this is mediated by the fibronectin type II domain. In cell culture systems, expression of Endo180 results in the rapid uptake of soluble collagens for delivery to lysosomal degradative compartments. Together with the observed restricted expression of Endo180 in both embryonic and adult tissue, we propose that Endo180 plays a physiological role in mediating collagen matrix remodelling during tissue development and homeostasis and that the observed receptor upregulation in pathological conditions may contribute to disease progression.
Since submission of this manuscript, two independent reports have demonstrated that fibroblasts from mice with a targeted Endo180 deletion show a collagen-binding defect (East et al., 2003; Engelholm et al., 2003).
* Corresponding author. E-mail address: clare.isacke{at}icr.ac.uk.
This article has been cited by other articles:
![]() |
F. Shi and J. Sottile Caveolin-1-dependent {beta}1 integrin endocytosis is a critical regulator of fibronectin turnover J. Cell Sci., July 15, 2008; 121(14): 2360 - 2371. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wienke, G. C. Davies, D. A. Johnson, J. Sturge, M. B.K. Lambros, K. Savage, S. E. Elsheikh, A. R. Green, I. O. Ellis, D. Robertson, et al. The Collagen Receptor Endo180 (CD280) Is Expressed on Basal-like Breast Tumor Cells and Promotes Tumor Growth In vivo Cancer Res., November 1, 2007; 67(21): 10230 - 10240. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Wagenaar-Miller, L. H. Engelholm, J. Gavard, S. S. Yamada, J. S. Gutkind, N. Behrendt, T. H. Bugge, and K. Holmbeck Complementary Roles of Intracellular and Pericellular Collagen Degradation Pathways In Vivo Mol. Cell. Biol., September 15, 2007; 27(18): 6309 - 6322. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Madsen, L. H. Engelholm, S. Ingvarsen, T. Hillig, R. A. Wagenaar-Miller, L. Kjoller, H. Gardsvoll, G. Hoyer-Hansen, K. Holmbeck, T. H. Bugge, et al. Extracellular Collagenases and the Endocytic Receptor, Urokinase Plasminogen Activator Receptor-associated Protein/Endo180, Cooperate in Fibroblast-mediated Collagen Degradation J. Biol. Chem., September 14, 2007; 282(37): 27037 - 27045. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sturge, S. K. Todd, G. Kogianni, A. McCarthy, and C. M. Isacke Mannose receptor regulation of macrophage cell migration J. Leukoc. Biol., September 1, 2007; 82(3): 585 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sulek, R. A. Wagenaar-Miller, J. Shireman, A. Molinolo, D. H. Madsen, L. H. Engelholm, N. Behrendt, and T. H. Bugge Increased Expression of the Collagen Internalization Receptor uPARAP/Endo180 in the Stroma of Head and Neck Cancer J. Histochem. Cytochem., April 1, 2007; 55(4): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sturge, D. Wienke, and C. M. Isacke Endosomes generate localized Rho-ROCK-MLC2-based contractile signals via Endo180 to promote adhesion disassembly J. Cell Biol., October 23, 2006; 175(2): 337 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Boskovic, J. N. Arnold, R. Stilion, S. Gordon, R. B. Sim, A. Rivera-Calzada, D. Wienke, C. M. Isacke, L. Martinez-Pomares, and O. Llorca Structural Model for the Mannose Receptor Family Uncovered by Electron Microscopy of Endo180 and the Mannose Receptor J. Biol. Chem., March 31, 2006; 281(13): 8780 - 8787. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tzircotis, R. F. Thorne, and C. M. Isacke Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding J. Cell Sci., November 1, 2005; 118(21): 5119 - 5128. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Thomas, M. Nakamura, D. Wienke, C. M. Isacke, A. Pozzi, and P. Liang Endo180 Binds to the C-terminal Region of Type I Collagen J. Biol. Chem., June 17, 2005; 280(24): 22596 - 22605. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sottile and J. Chandler Fibronectin Matrix Turnover Occurs through a Caveolin-1-dependent Process Mol. Biol. Cell, February 1, 2005; 16(2): 757 - 768. [Abstract] [Full Text] [PDF] |
||||